Health-Related Quality of Life and Survival in Metastasized Non-Small Cell Lung Cancer Patients with and without a Targetable Driver Mutation.
Nicole E BillingyVashti N M F TrompCorina J G Van Den HurkAnnemarie Becker-CommissarisIris WalravenPublished in: Cancers (2021)
M- NSCLC patients have less favorable HRQOL over time compared to M+ patients. Furthermore, clinically relevant HRQOL declines over time were significantly associated with worse survival. HRQOL can therefore play an important role in in shaping patients' expectations of their prognosis.